Effects of mixed hematopoietic chimerism in a mouse model of bone marrow transplantation for sickle cell anemia

Blood

Volumn 97, Issue 12, 2001, Pages 3960-3965

  Lannone, Robert ^a   Luznik, Leo ^a   Engstrom, Laura W ^a   Tennessee, Sherrie L ^a   Askin, Frederic B ^a   Casella, James F ^a   Kickler, Thomas S ^a   Goodman, Steven N ^a   Hawkins, Anita L ^a   Griffin, Constance A ^a   Noffsinger, Lori ^a   Fuchs, Ephraim J ^a,b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b Bunting Blaustein Cancer   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER MORTALITY; CHIMERA; FLOW CYTOMETRY; HEMATOPOIESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; MORBIDITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SICKLE CELL ANEMIA;

EID: 0035877966     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.12.3960     Document Type: Article

References (16)

1. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease: life expectancy and risk factors for early death. N Engl J Med. 1994;330:1639-1664.
2. Leikin SL, Gallagher D, Kinney TR, Sloane D, Klug P, Rida W. Mortality in children and adolescents with sickle cell disease. Pediatrics. 1989;84:500-508.
3. Johnson FL, Look AT, Gockerman J, Ruggiero MR, Dalla-Pozza L, Billings FT. Bone-marrow transplantation in a patient with sickle cell anemia. N Engl J Med. 1984;311:1317-1322.
4. Walters MC. Bone marrow transplantation for sickle cell disease: where do we go from here? J Pediatr Hematol Oncol. 1999;21:467-474.
5. Walters MC, Storb R, Patience M, et al. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Blood 2000;95:1918-1924.
6. Sandmaier BM, Maloney DG, Hegenbart U, et al. Nonmyeloablative conditioning for HLA-identical related allografts for hematologic malignancies [abstract]. Blood 2000;96:479a.
7. Franco RS, Lohmann J, Silberstein EB, et al. Time-dependent changes in the density and hemoglobin F content of biotin-labeled sickle cells. J Clin Invest. 1998;101:2730-2740.
8. Walters MC, Storb R, Patience M, et al. Stable mixed chimerism after bone marrow transplantation for sickle cell disease (SCD) [abstract]. Blood. 1999;94:645a.
9. Paszty, C, Brion CM, Manci E, et al. Transgenic knockout mice with exclusively sickle hemoglobin and sickle cell disease. Science. 1997;278:876-878.
10. Fuchs EJ, Matzinger P. B cells turn off virgin but not memory T cells. Science. 1992;258:1156-1159.
11. de Jong K, Emerson RK, Butler J, Paszty C, Mohandas N, Kuypers FA. Rapid turnover of red blood cells in sickle cell mice [abstract]. Blood. 1998;92:331a.
12. Styles LA, Vichinsky E. Effects of long-term transfusion regimen on sickle cell-related illness. J Pediatr. 1994;126:896-899.
13. Pegelow CH, Adams RJ, McKie V, et al. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr. 1995;126:896-899.
14. Schmalzer EA, Lee JO, Brown AK, Usami S, Chien S. Viscosity of mixtures of sickle and normal red cells at varying hematocrit levels. Implications for transfusion. Transfusion. 1987;27:228-233.
15. Petschow R, Petschow D, Bartels R, Baumann R, Bartels H. Regulation of oxygen affinity in blood of fetal, newborn and adult mice. Respir Physiol. 1978;35:271-282.
16. Fabry ME, Nagel RL, Pachnis A, Suzuka SM, Constantini F. High expression of human beta S-and alpha-globins in transgenic mice: hemoglobin composition and hematological consequences. Proc Natl Acad Sci U S A. 1992;89:12150-12154.